Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
Clinical trial NCT02507232 · TERMINATED
Trial details
- NCT number
- NCT02507232
- Sponsor
- Santosh Kesari
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-17
- Primary completion
- 2020-07-27
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.